MOS
FY2026 Q1 · Calendar Q2 2026
The Mosaic Company
Mosaic's Q1 FY2026 was defined by a severe EPS miss ($0.05 vs $0.24 estimated) as soaring sulfur and ammonia prices forced temporary phosphate production curtailments. Revenue of $3.0B slightly exceeded consensus. Management responded by cutting 2026 capex by $250M to $1.25B and launching a $50M cost-savings program. The potash segment stayed resilient on record Canpotex sales and strong Asian demand. Management tone shifted from confident in Q4 to cautious, with the bullish score falling from 70 to 45. Long-term growth drivers -- Mosaic Biosciences expansion and a new rare-earth extraction partnership with Rainbow Rare Earths -- remain intact but are not near-term catalysts. The stock declined 1.80% on the report with 2.06x baseline volume and continued to drift lower.
EPS surprise-79.6%
Market move-1.8%
